Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
8.15 USD
474.62 M USD
4.13 B USD
50.59 M
About Charles River Laboratories International, Inc.
Sector
CEO
James C. Foster
Website
Headquarters
Wilmington
Founded
1947
FIGI
BBG000BG5BL8
Charles River Laboratories International, Inc. engages in providing products and services to help pharmaceutical and biotechnology companies. It operates through the following segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions. The RMS segment includes its insourcing solutions business and Charles River accelerator and development lab footprint. The DSA segment offers regulatory-required safety testing of potential new drugs, vaccines, industrial and agricultural chemicals, consumer products, veterinary medicines, and medical devices. The Manufacturing Solutions segment focuses on microbial solutions and biologics solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
CRL5145816
Charles River Laboratories International, Inc. 4.0% 15-MAR-2031Yield to maturity
6.69%
Maturity date
Mar 15, 2031
CRL4900987
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
6.22%
Maturity date
May 1, 2028
CRL5145814
Charles River Laboratories International, Inc. 3.75% 15-MAR-2029Yield to maturity
6.05%
Maturity date
Mar 15, 2029
CRL4900988
Charles River Laboratories International, Inc. 4.25% 01-MAY-2028Yield to maturity
—
Maturity date
May 1, 2028
Explore more bonds
Frequently Asked Questions
The current price of CRL is 183.42 USD — it has decreased by −0.26% in the past 24 hours. Watch Charles River Laboratories International, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange Charles River Laboratories International, Inc. stocks are traded under the ticker CRL.
CRL stock has risen by 2.54% compared to the previous week, the month change is a −6.94% fall, over the last year Charles River Laboratories International, Inc. has showed a −22.64% decrease.
We've gathered analysts' opinions on Charles River Laboratories International, Inc. future price: according to them, CRL price has a max estimate of 250.00 USD and a min estimate of 164.00 USD. Watch CRL chart and read a more detailed Charles River Laboratories International, Inc. stock forecast: see what analysts think of Charles River Laboratories International, Inc. and suggest that you do with its stocks.
CRL stock is 3.02% volatile and has beta coefficient of 1.58. Track Charles River Laboratories International, Inc. stock price on the chart and check out the list of the most volatile stocks — is Charles River Laboratories International, Inc. there?
Today Charles River Laboratories International, Inc. has the market capitalization of 9.52 B, it has increased by 1.71% over the last week.
Yes, you can track Charles River Laboratories International, Inc. financials in yearly and quarterly reports right on TradingView.
Charles River Laboratories International, Inc. is going to release the next earnings report on Feb 12, 2025. Keep track of upcoming events with our Earnings Calendar.
CRL earnings for the last quarter are 2.59 USD per share, whereas the estimation was 2.42 USD resulting in a 6.91% surprise. The estimated earnings for the next quarter are 2.54 USD per share. See more details about Charles River Laboratories International, Inc. earnings.
Charles River Laboratories International, Inc. revenue for the last quarter amounts to 1.01 B USD, despite the estimated figure of 975.99 M USD. In the next quarter, revenue is expected to reach 985.70 M USD.
CRL net income for the last quarter is 68.68 M USD, while the quarter before that showed 89.99 M USD of net income which accounts for −23.68% change. Track more Charles River Laboratories International, Inc. financial stats to get the full picture.
No, CRL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 21.80 K employees. See our rating of the largest employees — is Charles River Laboratories International, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Charles River Laboratories International, Inc. EBITDA is 951.39 M USD, and current EBITDA margin is 23.62%. See more stats in Charles River Laboratories International, Inc. financial statements.
Like other stocks, CRL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Charles River Laboratories International, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Charles River Laboratories International, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Charles River Laboratories International, Inc. stock shows the sell signal. See more of Charles River Laboratories International, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.